Q4 2025 Earnings Call March 31, 2026 5:00 PM EDTCompany ParticipantsJolie Kahn - Chief Executive OfficerChristopher ...

When competitors have access to the same AI tools and data, what defines company success is the decisions that are made and acted upon.

Streamlining clinical trials, harmonising regulations and improving access to capital should be driving biotech efforts, ...

Montana-based awardees called the terminations ‘devastating’ — and based on a false presumption that tribal initiatives fall ...

Whenever anyone is in a pre-retirement stage, one thing that often gets overlooked can become a major problem during ...

The Idaho Senate is one of the last stops for a bill that would let Attorney General Raúl Labrador seek to temporarily ...

Welcome to the earnings call of Aumann AG regarding the full year figures for 2025. The company's CEO, Sebastian Roll; and CFO, Jan-Henrik Pollitt, will guide you through the presentation and the ...

The New Income Tax Act comes into effect today, April 1, 2026. Get real-time updates on tax slabs, increased standard ...

Marx built part of his system on the belief that capital would create the “great reserve army of the unemployed,” and modern ...

Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity. BioSpace spoke to four industry executives about key issues facing those ...

Murali Krishna Gunturu, Managing Partner at Inflexor Ventures, details the firm’s thinking behind backing science- and tech-led companies, what signals matter before product–market fit is visible, and ...